Therapeutic Targeting of TIM-4-L with Engineered T Cells for Acute Myeloid Leukemia.
Cieniewicz B, Oliveira E, Saxton M, Torabi D, Bhatta A, Kukutla P, Arballo A, Yang Z, Yu B, Fate M, Ning H, Corey L, Maiti A, Corey D.
Cieniewicz B, et al. Among authors: kukutla p.
Clin Cancer Res. 2024 May 1;30(9):1878-1888. doi: 10.1158/1078-0432.CCR-23-3044.
Clin Cancer Res. 2024.
PMID: 38451195